Utilizing NOACs in non-valvular atrial fibrillation patients undergoing PCI

Abstract

Learning Objectives

  • Describe the complex nature and current recommendations for antithrombotic therapy for non-valvular AF patients undergoing PCI  
  • Define the complications associated with TAT  
  • Summarize the latest data utilizing NOAC therapy in AF patients undergoing PCI

Visit the site here

Citation
Byrne R, Hohnloser S, Nickenig G, Sendon JL and Zamarano JL, Radcliffe-CME, Feb 2018.